Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001780081-26-000002

Director sold 7,229 shares at $39.66 ($286,715)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Krainer Adrian R. Director 2026-03-02 Sale 10b5-1 −7,229 $39.66 $286,715 316,545 D: show line 1 in the form
Open-market sales · 7,229 sh · avg $39.66 · $286,715
Loading xslF345X05/form4-03042026_090337.xml…